Objectives: Glycated hemoglobin (HbA1c) is the most commonly used glycemic index among diabetic patients. The present study sought to investigate the relationship between HbA1c and lipid parameters among healthy pregnancies and gestational diabetic cases. Materials and Methods: Seventy-five Saudi pregnant women within the age group of 19 to 43 years were selected for this crosssectional study. The participants were categorized into with and without gestational diabetes (GDM), all of whom were non-smokers; in addition, they neither had a previous history of chronic illnesses nor were they on any medications which could alter lipid profile and HbA1c concentrations. Totally, 75 g of oral glucose tolerance test (OGTT) was utilized to identify 25 women with GDM. All biochemical tests including HbA1c, fasting blood sugar (FBG), total cholesterol (TC), low-density lipoprotein (LDL-cholesterol), triglycerides (TG), and high-density lipoprotein (HDL-cholesterol) were performed by a biochemical auto-analyzer. The collected data were statistically analyzed using a paired student's t test. The P values of <0.05 were considered statistically significant on all the analyses related to healthy pregnancies and those associated with GDM.
Introduction
Gestational diabetes (GDM) is a potentially serious condition which affects several pregnancies worldwide, the prevalence of which has growingly increased by 2 to 3 folds in the last few decades. GDM is defined as the impaired glucose tolerance which causes high levels of blood glucose and is essentially identified during pregnancy (1) . It occurs due to the onset of the series related to the major metabolic disturbance in carbohydrate metabolism. In addition, abnormal levels of plasma lipids and lipoprotein concentrations are typically encountered in these individuals. It is a well-known fact that major alterations in carbohydrate, lipid, and amino acid metabolism take place even in normal pregnant women mainly due to the hormonal changes and mild insulin resistance (2) . Those women who had limited beta cell capacity for compensating the pregnancy-induced insulin resistance due to a variation in the genes involved in insulin secretion and carbohydrate utilization are likely to develop GDM (3) . Lipid metabolism in normal pregnancy undergoes adaptive changes. Physiologically, a 2 to 3 times increment in plasma triglycerides (TG) is found in second and third trimesters of gestation. This is frequently accompanied by a lesser degree of increase in the levels of the total cholesterol (TC), high-density lipoprotein (HDL-cholesterol), and low-density lipoprotein (LDLcholesterol). Further, postpartum, TC, HDL-cholesterol, and TG demonstrate a decline while the LDL-cholesterol level tends to remain unchanged (4) (5) (6) . Previous studies detected a relationship between the parameters of the lipid, the degree of glucose tolerance, the function of the endothelial cell, and risk of developing cardiovascular diseases among pregnant females. Furthermore, it was revealed that serum TG values observed during the first trimester of gestation have a good predictive utility for determining glucose tolerance during the entire phase of pregnancy (5) . An increased level of oxidative stress and inflammation during pregnancy may have a consequence on long-term cardiovascular health, especially in women having the predisposition to other risk factors responsible for a variety of cardiovascular illnesses (7) .
Glycated hemoglobin (HbA1c) is a commonly used indicator of blood glucose levels in diabetics. It reflects the previous 8-10 weeks average level of plasma glucose (8) . The HbA1c helps to speculate the risk for developing the array of diabetic complications, along with indicating the mean blood glucose level (8) . A significant rise in HbA1c level is considered to be an independent risk factor for causing derangement in lipid parameters which may lead to coronary heart disease and stroke in people with or without diabetes (9) . Therefore, a high value of HbA1c is linked to deranged lipid profile. Pregnancy is not an exception. In other words, diabetes and pregnancy have a cumulative role in causing a major disruption in metabolic rhythm which eventually results in developing an atherogenic lipid profile. This, in turn, has negative implications on both maternal and fetal health. Diabetic dyslipidemia is strongly related to the insulin resistance and abnormal lipid fractions leading to elevated levels of TG and LDL-cholesterol while decreasing the levels of HDLcholesterol. An approximate rise of 18% was estimated in the risk factors of several cardiovascular diseases for each 1% increment in absolute value of HbA1c among diabetic patients. Moreover, a positive association between HbA1c and the development of cardiovascular diseases was even observed in non-diabetic patients having a normal range of HbA1c values (10) .
Alteration in the lipid profile is known to occur in GDM (11). Jiang et al indicated that increased levels of TC or TG during the prevalence of dyslipidemia among pregnant mothers are frequently associated with an outcome favoring a chance of having a preterm delivery (12) . Premature birth or birth of an infant at less than 37 weeks of gestational age is the second most common cause of death in children less than 5 years of age. Additionally, it is related to the increased risk of developing derangement in metabolic processes later in life. These may further prove to be detrimental to both mother and child health (13) .
So far, no conclusive studies have been conducted in Saudi Arabia regarding the association between the HbA1c and lipid profile among pregnant women. Therefore, this study focused on highlighting the relationship between the above-mentioned factors among pregnant women in Saudi Arabia and to prognosticate if HbA1c can be used as an independent marker of dyslipidemia among GDM cases.
Materials and Methods
The present cross-sectional study was implemented during (November) 2017-(February) 2018 and was approved by the Research Ethics Committee of the College of Applied Medical Sciences in Taif University and Primary Health Care Center in Mecca. In addition, all participants were informed about the research objectives and signed the consent form before completing the questionnaire and collecting the blood samples.
Based on the number of participants who completed the questionnaires and fulfilled the criteria for inclusion, a total of 75 pregnant women (50 healthy control vs. 25 gestational diabetic cases) within the age range of 19-43 years were recruited for the current study. Further, these participants were selected during their routine antenatal visit to a primary health care center in Mecca, Saudi Arabia and were within the end of the first trimester and beginning of the second trimester. Furthermore, they responded to the questionnaire containing information about their age, educational level, number of pregnancies, self-history and family history of GDM, as well as the family history of diabetes mellitus (DM), diet, lifestyle, and indulgence in physical exercises. Based on an initial screening for fasting blood glucose value and considering the risk factors, the GDM of 25 women was diagnosed based on 75-g oral glucose tolerance test (OGTT) with 3 glucose values of venous blood using the hexokinase method. Moreover, the standard method of American Diabetes Association (ADA) was applied regarding having at least 2 values exceeding the set values (95, 180, and 155 mg/dL) in the venous sample (14) . The selected patients had no previous history of medical illnesses such as hemoglobinopathy, iron-deficiency anemia, thyroid diseases, beforeconception diabetes mellitus, hypertension, renal, cardiac diseases. Additionally, they were all non-smokers while they were not on any medications or supplements that could modify lipid profile, insulin levels, and HbA1c concentrations.
Biochemical tests including HbA1c, fasting blood glucose (FBG), TC, LDL-cholesterol, TG, and HDL-cholesterol were conducted employing a biochemical automated analyzer in the primary health care centre in Mecca, Saudi Arabia. Samples for serum lipid profile parameters (i.e., TC, LDL-cholesterol, TG, and HDL-cholesterol) and FBG were collected after 10-12 hours of overnight fasting. In addition, blood withdrawn in plain (red-top) tube was first allowed to clot and then centrifuged at 3000 rpm for 10 minutes in order to separate the serum. TC was enzymatically determined in a series of coupled reactions by the cholesterol oxidase/peroxidase aminophenazone (CHOD-PAP) colorimetric method and finally produced a color whose intensity was proportional to the cholesterol concentration at 500 nm; TG was determined in a similar way by glycerophosphate oxidase and peroxidase (GPO-PAP method) using the sequential enzymatic reactions which hydrolyzed TG into glycerol. Further reactions produced a color product which was measured at 500 nm. Furthermore, HDL-cholesterol was estimated by the action of polyethylene glycol (PEG)-coupled cholesteryl esterase-cholesterol oxidase (CHE-CHO) and then, the absorption was measured at 600 nm after final peroxidase reaction. Moreover, LDL-cholesterol was determined to employ the enzymatic photometric method (CHE-CHO; peroxidase) and its concentration was photometrically calculated. Additionally, FBG was obtained by glucose oxidase (GOD) and peroxidase (POD) enzymatic method to form a red dye which was quantitated at 505 nm. The reference range for serum lipids were considered as follows: TC<200 mg/dL; LDL-cholesterol <130 mg/dL; TG<150 mg/dL and HDL-cholesterol ˃50 mg/dL; in addition, the reference range for FBG was considered to be 70-100 mg/ dL. Further, blood sample for HbA1c was collected in a lavender top tube with ethylenediaminetetraacetic acid (EDTA) and analyzed on the same day of collection. The reference range for HbA1c was considered from 4.3% to 6.0%. Furthermore, the ratio of TG to HDL-cholesterol was calculated from their measured values; its reference range considered to be < 2.
Finally, the collected data were statistically analyzed by the SPSS software, version 22 using the student's t test. The P values of <0.05 were considered statistically significant on all the measurements of healthy pregnant women and those with GDM.
Results
The mean age of 75 pregnant females included in this study was 30.6 years. Moreover, the mean age of 50 healthy control group was equal to 29.7 years and that of 25 women with GDM was estimated to be 31.4 years. The statistical analysis of demographics, obstetrics, health history, and lifestyle of those women with and without GDM are presented in Table 1 . As shown, there is no significant variation (P ˃ 0.05) in women with and without GDM based on their age, educational level, the number of pregnancies, previous history of GDM, family history of GDM and DM, diet, lifestyle, and physical exercises. Table 2 demonstrates the comparison of the lipid profile of women in both groups. Several variables are examined including TC, LDL-cholesterol, TG, HDL-cholesterol, as well as the ratio of TG and HDL-cholesterol. Based on their P values, TC, LDL-cholesterol, and TG represent no remarkable variation between the 2 groups of pregnant women whereas HDL-cholesterol and the ratio of TG and HDL-cholesterol indicate a significant difference between the women with and without GDM (P < 0.05). Additionally, the means and standard deviations of HDL-C, TG, and HDL-C ratio are 62.12± 15.32, 49.00± 8.54, as well as 1.76± 0.90 and 2.70± 1.6 in women with and without GDM, respectively.
In addition, the comparison of the mean values of FBG and HbA1c demonstrated in Table 3 . As shown, there is a high degree of variation in these values between healthy pregnant women and women with GDM (P < 0.05). Further, the mean and standard deviation of FBG is equal to 93.92± 6.14 and 118.84± 6.88 and that of the HbA1c is 
Discussion
GDM has many deleterious immediate and long-term consequences for both mother and neonates. Pregnant women with high levels of blood glucose are susceptible to the risk of developing pre-eclampsia, preterm deliveries, cesarean delivery, as well as type-II diabetes later in their life. The neonates of these mothers are typically macrosomic due to the deranged intrauterine metabolic environment; that is, they develop respiratory distress and hyperbilirubinemia (15) . Therefore, the ill-effects of GDM on lipid metabolism still remains ambiguous since GDM leads to alterations in maternal metabolic fuels, which is quite often associated with a variety of complications. Furthermore, the abnormalities of carbohydrate metabolism in GDM may affect lipid metabolism at large and both acting synergistically may act as important predictors of hypertension, dyslipidemia, and cardiovascular diseases (16) . Accordingly, studies indicating an association between GDM and lipid profile are helpful in avoiding cardiovascular complications and decreasing the morbidity and mortality ratios of gestational diabetic mothers and neonates.
Several studies demonstrated marked alterations in values of plasma lipid profile and concentrations of lipoprotein (17) (18) (19) . The current study was designed to investigate the lipid profile and glucose tolerance in GDM women and compare it with normal pregnant women. The results of previous studies revealed that plasma glucose values decrease during pregnancy due to its utilization by the growing fetus (20) . In the present study, the fasting values of blood glucose in women with GDM were significantly increased (P < 0.001) and the actual levels were 118.84 ± 6.88 mg/dL when compared with non-GDM levels (93.92 ± 6.14 mg/dL). Taricco et al (21) obtained similar results respecting the increased levels of plasma glucose in maternal diabetes. Furthermore, Khan et al (22) found that the value of FBG was 112 ± 8.70 mg/dL in GDM groups compared to 87 ± 6.90 mg/ dL in healthy pregnant women (P < 0.001). Contrarily, Lenin et al (19) indicated no significant difference in FBG value among non-GDM and GDM groups among an Indian population. They reported an FBG measure of 72.45± 7.23 mg/dL and 74.3 ± 9.18 mg/dL (P = 0.23) in the 2 groups, respectively. The results of the current study further revealed that glycated hemoglobin values elevated in GDM compared to the healthy pregnant women; in the present study, a mean of 6.33 ± 0.36% and 5.15 ± 0.33% were obtained in GDM and healthy controls, respectively. Ghafoor et al (23) compared HbA1c levels in non-diabetic pregnant women and GDM women of Pakistan and observed values of 6.04 ± 0.16% and 7.50 ± 0.43% among the 2 groups, respectively (P < 0.001). Moreover, Khan et al reported quite similar results in their study where they compared glycated hemoglobin of the 2 groups and found a value of 6.6± 1.30% and 4.9 ± 0.44% for GDM cases and healthy control women, respectively. Additionally, McGrowder et al (24) studied lipid profile and clinical characteristics of the women with GDM mellitus and preeclampsia in West Indies and represented that HbA1c was higher in women with GDM (5.90 ± 0.34%) compared to its value among the control group (4.60 ± 0.67%) with a P value equal to 0.001.
HbA1c is an indispensable means for managing longterm glycemic index and an invaluable marker of plasma lipid profile. Therefore, close observation of glycemic index using glycated hemoglobin is believed to be of high prognostic value, especially in diabetic patients who are predisposed to cardiovascular complications (25) . It is well-known that an increased level of HbA1c poses an enormous amount of risk for the development of cardiovascular diseases including stroke in people who are already diagnosed as diabetic (26) . The results of a research performed on 11 092 non-diabetic patients as part of community-based population study revealed that high HbA1c numbers had a strong association with developing the highly favorable chance of having cardiovascular disease in near-future and greater mortality rates among these subjects (27) . HbA1c reflects the previous 8-10 weeks glycemic index in an individual and poor glycemic control is known to be associated with elevated cholesterol, triglycerides, and low-density lipoprotein. Therefore, estimating HbA1c at an early stage can help decrease the risk of mortality and morbidity of both mother and the conceptus by early detection of maternal dyslipidemia and its prompt treatment. Hyperlipidemia typically occurs during normal pregnancy and alterations in lipid profile is known to occur in GDM (11) . Significantly elevated levels of HbA1c in GDM and its relation to lipid profile were reported by several researchers (19, 22, 23) . McGrowder at al indicated HbA1c concentration was higher in women with GDM (P = 0.001); in addition, they found that TC and triglycerides were significantly high in these women (P=0.039 for TC and P = 0.033 for TG). However, HDLcholesterol was non-significantly low. Baxi et al (28) Additionally, the results of the current study demonstrated a significant decrease in HDL-cholesterol while indicating a significant increase in TG: HDL-cholesterol ratio in GDM cases compared to the healthy pregnant women with a P < 0.001 in the case of HDL-cholesterol and P < 0.01 in the case of TG: HDL-cholesterol ratio. Although TG levels in the present study revealed no significant increase in GDM pregnancies, it is on the higher side when compared to TG levels in normal pregnant women (122.52 ± 51.50 mg/dL in the case of GDM and 105.26 ± 41.70 mg/dL in normal pregnant women). In addition, increased levels of triglyceride were reported by Kjos et al (11) . Another study by Aura et al (33) evaluated the incidence of impaired lipid profile parameters in subjects with GDM and their relationship with gestation, fetal complications, and metabolic syndrome variables of the mother; they reported decreased HDL-cholesterol levels while increased TG levels in GDM cases. Further, Ryckman et al (34) observed that triglycerides significantly increased among female subjects diagnosed with GDM in contrast to the healthy ones. Furthermore, HDL-C levels significantly decreased in GDM cases compared to those without GDM in the second and third trimesters of pregnancy. However, Sobki at al (35) concluded that lipid parameters in the serum of pregnant subjects demonstrated no significant difference between GDM patients and healthy females. By estimating the serum TG, HDL-cholesterol, and most importantly, TG: HDL-cholesterol ratio, the severity of abnormal maternal metabolism, as well as the degree of dyslipidemia can be predicted which, therefore, leads to better antenatal care for avoiding further complications both for the mother and the neonate. Moreover, in one of the findings of American Heart Association, it was revealed that the chance of having heart diseases was significantly increased in people having high ratios of triglyceride and HDL cholesterol compared to those having lower ratios (36) .
The limitations of the study included the small sample size. A larger number of participants in the study provides more comprehensive results. Additionally, the present study was not extended throughout the pregnancy, namely, until the end of the third trimester. This posed a restriction for generalizing the association between HbA1c and lipid profile among pregnant women at all gestational ages. It would be interesting to follow the GDM pregnancies through each trimester to better correlate the blood glucose levels with maternal lipid metabolism.
Conclusions
The results of the study prove beyond doubt that blood levels of glucose, glycated hemoglobin, triglycerides, and high-density lipoprotein play significantly important roles in developing dyslipidemia in GDM state. Although it is known that lipid parameters increase even in normal pregnancy, how it increases in GDM is different; In addition, based on the results, a significant decrease does not typically occur in HDL-cholesterol in normal pregnancies. We need a highly larger sample size in order to further validate the results and demonstrate that glycated hemoglobin can be exploited as a potential index of abnormal lipid profile in GDM.
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